Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 41
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Int J Tuberc Lung Dis ; 23(9): 1024-1028, 2019 09 01.
Artigo em Inglês | MEDLINE | ID: mdl-31615611

RESUMO

SETTING: Early diagnosis of latent tuberculous infection (LTBI) should be pursued in healthcare workers (HCWs). While HCWs in hospitals are screened for LTBI, HCWs in outpatient settings are usually not. In 2017, in Italy, a tuberculosis (TB) infected paediatrician working in an outpatient vaccination service infected 15 adults and nine children. The investigation involved 2490 children and 151 adults. Among children, nine were tuberculin skin test-positive, and four developed active TB. Among 123 adult contacts with longer exposure, seven were interferon-gamma release assay (IGRA) positive and none had active TB. Among 28 close contacts, eight had a positive IGRA, and three had pulmonary TB. The total outbreak cost €1 017 903.OBJECTIVE: To compare the outbreak cost with those of potential screening programme strategies.RESULTS: Regular screening of paediatric outpatient HCWs would have cost between €2592 and €11 373. Extending the screening to all outpatient HCWs (caring for adults and children) would have cost between €66 384 and €155 043. Investigating only close contacts would have cost €42 857.CONCLUSION: Each of these screening strategies would have been cost-effective compared with the outbreak investigation occurring in real life with a cut-off of 474 for the maximum number of tested outpatient HCWs needed for the screening strategy to be cost-saving.


Assuntos
Pessoal de Saúde , Tuberculose Latente/diagnóstico , Programas de Rastreamento/métodos , Tuberculose Pulmonar/diagnóstico , Adulto , Criança , Análise Custo-Benefício , Surtos de Doenças , Humanos , Testes de Liberação de Interferon-gama , Itália , Tuberculose Latente/epidemiologia , Programas de Rastreamento/economia , Pacientes Ambulatoriais , Teste Tuberculínico , Tuberculose Pulmonar/epidemiologia
3.
Biomed Res Int ; 2018: 2012078, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30065933

RESUMO

The availability of genomic datasets in association with clinical, phenotypic, and drug sensitivity information represents an invaluable source for potential therapeutic applications, supporting the identification of new drug sensitivity biomarkers and pharmacological targets. Drug discovery and precision oncology can largely benefit from the integration of treatment molecular discriminants obtained from cell line models and clinical tumor samples; however this task demands comprehensive analysis approaches for the discovery of underlying data connections. Here we introduce PATRI (Platform for the Analysis of TRanslational Integrated data), a standalone tool accessible through a user-friendly graphical interface, conceived for the identification of treatment sensitivity biomarkers from user-provided genomics data, associated with information on sample characteristics. PATRI streamlines a translational analysis workflow: first, baseline genomics signatures are statistically identified, differentiating treatment sensitive from resistant preclinical models; then, these signatures are used for the prediction of treatment sensitivity in clinical samples, via random forest categorization of clinical genomics datasets and statistical evaluation of the relative phenotypic features. The same workflow can also be applied across distinct clinical datasets. The ease of use of the PATRI tool is illustrated with validation analysis examples, performed with sensitivity data for drug treatments with known molecular discriminants.


Assuntos
Genômica , Neoplasias , Medicina de Precisão , Biomarcadores , Humanos , Proteômica
4.
Appl Environ Microbiol ; 84(7)2018 04 01.
Artigo em Inglês | MEDLINE | ID: mdl-29352084

RESUMO

Human bocavirus (HBoV) has been shown to be a common cause of respiratory infections and gastroenteritis in children. Recently, HBoVs have been detected in sewage and river waters in Italy and worldwide. However, studies on their presence in other water environments and in bivalve mollusks are not yet available. In this study, 316 bivalve shellfish samples collected in three Italian regions over a 6-year period (2012 to 2017) were analyzed by nested PCR and sequencing using broad-range primer pairs targeting the capsid proteins VP1 and VP2 of HBoV. The virus was detected in 27 samples (8.5% of the total samples), and a statistically significant difference was found within the three regions. A further 13 samples, collected in geographic and temporal proximity to positive samples, were included in the study to assess the spread of HBoV in shellfish production areas at the time of contamination. Twelve of these additional samples were found to be positive for HBoV. All positive samples in this study were characterized as HBoV species 2 (17 samples; 8 different sequences) or species 3 (22 samples; 4 different sequences). This study reports the occurrence of HBoV in bivalve shellfish and shows evidence of considerable spatial spread of the virus throughout shellfish production areas. Further studies are needed to elucidate both the role of HBoV as an agent of gastroenteritis and the risk for foodborne transmission of this virus.IMPORTANCE Human bocavirus is recognized as an important cause of acute respiratory tract infections and has recently been considered an etiological agent of gastroenteritis in the pediatric population. Our findings document that HBoVs are detected in bivalve shellfish with a relevant prevalence and suggest that an assessment of the risk for foodborne transmission of these viruses should be undertaken.


Assuntos
Bivalves/virologia , Microbiologia de Alimentos , Bocavirus Humano/genética , Bocavirus Humano/isolamento & purificação , Frutos do Mar/virologia , Animais , Variação Genética , Itália , Reação em Cadeia da Polimerase , Análise de Sequência de DNA
5.
Transbound Emerg Dis ; 65(1): 16-21, 2018 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-29134762

RESUMO

Canine parvovirus (CPV) is an important infectious agent of domestic and wild carnivores, responsible for severe and often fatal haemorrhagic gastroenteritis and leukopenia. This paper reports the genomic characterization of a CPV strain collected from a dog recently imported to Italy from Thailand. The virus was detected in all tissue samples collected. The whole genome encompassing the two open reading frames encoding for non-structural (NS1/NS2) and structural (VP1/VP2) proteins was amplified and sequenced. On the basis of genetic analysis of the VP2 gene, the isolate was characterized as CPV-2c, but it presented genetic signatures typical of Asian strains. Sequence analysis revealed the presence of amino acid changes never observed in European CPV-2c strains (NS1: Ile60Val, Tyr544Phe, Glu545Val, Leu630Pro; VP2: Ala5Gly, Phe267Tyr, Tyr324Ile, Gln370Arg). By phylogenetic analysis of full-length VP2 gene, the analysed strain clustered together with Asian viruses. Therefore, a possible introduction of the virus from Asia through the imported dog was suggested, thus confirming the important role of movement of dogs in the global spread of viruses. In addition, full-length genome analysis could help better trace the spread of canine viruses through different continents.


Assuntos
Doenças Transmissíveis Importadas/veterinária , Doenças do Cão/virologia , Variação Genética , Genoma Viral/genética , Infecções por Parvoviridae/veterinária , Parvovirus Canino/genética , Animais , Doenças Transmissíveis Importadas/virologia , Cães , Evolução Fatal , Itália , Infecções por Parvoviridae/virologia , Parvovirus Canino/isolamento & purificação , Filogenia , Análise de Sequência de DNA/veterinária , Tailândia , Proteínas não Estruturais Virais/genética , Proteínas Estruturais Virais/genética
6.
Anat Histol Embryol ; 47(1): 11-20, 2018 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-29094769

RESUMO

In this study, mesenchymal stem cells were isolated from rat adipose tissue (AD-MSCs) to characterize and differentiate them into endothelial-like cells. AD-MSCs were isolated by mechanical and enzymatic treatments, and their identity was verified by colony-forming units (CFU) test and by differentiation into cells of mesodermal lineages. The endothelial differentiation was induced by plating another aliquot of cells in EGM-2 medium, enriched with specific endothelial growth factors. Five subcultures were performed. The expression of stemness genes (OCT4, SOX2 and NANOG) was investigated. The presence of CD90 and the absence of the CD45 were evaluated by flow cytometry. The endothelial-like cells were characterized by the evaluation of morphological changes and gene expression analysis for endothelial markers (CD31, CD144, CD146). Characterization of AD-MSCs showed their ability to form clones, to differentiate in vitro and the OCT-4, SOX-2, NANOG genes expression. Immunophenotypic characterization showed the CD90 presence and the CD45 absence. The endothelial-like cells showed morphological changes, the expression of CD31, CD144, CD146 genes and the presence of CD31 membrane receptor. Matrigel assay showed their ability to form network and vessels-like structures. This study lays the foundations for future evaluation of the potential AD-MSCs pro-angiogenic and therapeutic role.


Assuntos
Tecido Adiposo/citologia , Diferenciação Celular/fisiologia , Células Endoteliais/citologia , Células-Tronco Mesenquimais/citologia , Ratos Wistar/anatomia & histologia , Animais , Antígenos CD/genética , Antígenos CD/metabolismo , Antígeno CD146/genética , Antígeno CD146/metabolismo , Caderinas/genética , Caderinas/metabolismo , Colágeno , Meios de Cultura , Regulação para Baixo , Combinação de Medicamentos , Citometria de Fluxo , Perfilação da Expressão Gênica , Laminina , Antígenos Comuns de Leucócito/metabolismo , Proteína Homeobox Nanog/genética , Proteína Homeobox Nanog/metabolismo , Fator 3 de Transcrição de Octâmero/genética , Fator 3 de Transcrição de Octâmero/metabolismo , Molécula-1 de Adesão Celular Endotelial a Plaquetas/genética , Molécula-1 de Adesão Celular Endotelial a Plaquetas/metabolismo , Proteoglicanas , Ratos , Fatores de Transcrição SOXB1/genética , Fatores de Transcrição SOXB1/metabolismo , Antígenos Thy-1/metabolismo , Regulação para Cima
7.
Transbound Emerg Dis ; 64(4): 1243-1253, 2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-27041547

RESUMO

The genus Pestivirus, which belongs to the Flaviviridae family, includes ssRNA+ viruses responsible for infectious diseases in pigs, cattle, sheep, goats and other domestic and wild ruminants. Like most of the RNA viruses, pestivirus has high genome variability with practical consequences on disease epidemiology, diagnosis and control. In addition to the officially recognized species in the genus Pestivirus, such as BVDV-1, BVDV-2, BDV and CSFV, other pestiviruses have been detected. Furthermore, most of the ruminant pestiviruses show low or absent species specificity observed in serological tests and are able to infect multiple species. Particularly, small ruminants are receptive hosts of the most heterogeneous group of pestiviruses. The aim of this study was to carry out the molecular characterization of pestiviruses isolated from sheep and goats in Sicily, Italy. Phylogenetic analysis of two viral genomic regions (a fragment of 5'-UTR and the whole Npro regions) revealed the presence of different pestivirus genotypes in the analysed goat and sheep herds. Two of five viral isolates were clustered with BVDV-1d viruses, a strain widespread in Italy, but never reported in Sicily. The other three isolates formed a distinct cluster with high similarity to Tunisian isolates, recently proposed as a new pestivirus species. This represents the first evidence for Tunisian-like pestivirus presence in small ruminants in Italy. Furthermore, one of the isolates was collected from a goat, representing the first isolation of Tunisian-like pestivirus from this species.


Assuntos
Genoma Viral , Doenças das Cabras/epidemiologia , Infecções por Pestivirus/veterinária , Pestivirus/genética , Doenças dos Ovinos/epidemiologia , Animais , Vírus da Diarreia Viral Bovina Tipo 1/classificação , Vírus da Diarreia Viral Bovina Tipo 1/genética , Vírus da Diarreia Viral Bovina Tipo 1/isolamento & purificação , Genótipo , Doenças das Cabras/virologia , Cabras , Pestivirus/classificação , Pestivirus/isolamento & purificação , Infecções por Pestivirus/epidemiologia , Infecções por Pestivirus/virologia , Filogenia , RNA Viral/genética , Análise de Sequência de RNA/veterinária , Ovinos , Doenças dos Ovinos/virologia , Sicília/epidemiologia
8.
QJM ; 109(7): 497, 2016 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-27026695
9.
Int J Antimicrob Agents ; 46(1): 8-12, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-25982915

RESUMO

Clostridium difficile infection (CDI) has become the most frequent cause of nosocomial infectious diarrhoea in developed countries, causing an increase in mortality, recurrences or treatment failure. In the search for new and more effective drugs, researchers recently turned their attention to tigecycline, a broad-spectrum antibiotic of the glycylglycine class available as an intravenous formulation for human use, which has also shown in vitro activity against C. difficile. We performed a literature review of articles addressing in vitro as well as in vivo studies and case reports on the effectiveness of tigecycline, whose use is promising especially in light of its high faecal excretion. The available evidence suggests that tigecycline could play a role as an alternative therapeutic option for critically ill patients or cases of refractory CDI.


Assuntos
Antibacterianos/uso terapêutico , Clostridioides difficile/efeitos dos fármacos , Infecções por Clostridium/tratamento farmacológico , Diarreia/tratamento farmacológico , Minociclina/análogos & derivados , Antibacterianos/farmacologia , Infecções por Clostridium/microbiologia , Diarreia/microbiologia , Humanos , Minociclina/farmacologia , Minociclina/uso terapêutico , Tigeciclina , Resultado do Tratamento
11.
Cell Death Dis ; 4: e891, 2013 Oct 31.
Artigo em Inglês | MEDLINE | ID: mdl-24176849

RESUMO

Triple-negative breast cancers (TNBCs) are clinically aggressive forms associated with a poor prognosis. We evaluated the cytotoxic effect exerted on triple-negative MDA-MB231 breast cancer cells both by parthenolide and its soluble analogue dimethylamino parthenolide (DMAPT) and explored the underlying molecular mechanism. The drugs induced a dose- and time-dependent decrement in cell viability, which was not prevented by the caspase inhibitor z-VAD-fmk. In particular in the first hours of treatment (1-3 h), parthenolide and DMAPT strongly stimulated reactive oxygen species (ROS) generation. The drugs induced production of superoxide anion by activating NADPH oxidase. ROS generation caused depletion of thiol groups and glutathione, activation of c-Jun N-terminal kinase (JNK) and downregulation of nuclear factor kB (NF-kB). During this first phase, parthenolide and DMAPT also stimulated autophagic process, as suggested by the enhanced expression of beclin-1, the conversion of microtubule-associated protein light chain 3-I (LC3-I) to LC3-II and the increase in the number of cells positive to monodansylcadaverine. Finally, the drugs increased RIP-1 expression. This effect was accompanied by a decrement of pro-caspase 8, while its cleaved form was not detected and the expression of c-FLIPS markedly increased. Prolonging the treatment (5-20 h) ROS generation favoured dissipation of mitochondrial membrane potential and the appearance of necrotic events, as suggested by the increased number of cells positive to propidium iodide staining. The administration of DMAPT in nude mice bearing xenografts of MDA-MB231 cells resulted in a significant inhibition of tumour growth, an increment of animal survival and a marked reduction of the lung area invaded by metastasis. Immunohistochemistry data revealed that treatment with DMAPT reduced the levels of NF-kB, metalloproteinase-2 and -9 and vascular endothelial growth factor, while induced upregulation of phosphorylated JNK. Taken together, our data suggest a possible use of parthenolide for the treatment of TNBCs.


Assuntos
Autofagia/efeitos dos fármacos , Espécies Reativas de Oxigênio/metabolismo , Sesquiterpenos/farmacologia , Animais , Neoplasias da Mama/tratamento farmacológico , Neoplasias da Mama/metabolismo , Proteína Reguladora de Apoptosis Semelhante a CASP8 e FADD/metabolismo , Cálcio/metabolismo , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Proteína de Domínio de Morte Associada a Fas/metabolismo , Feminino , Humanos , Potencial da Membrana Mitocondrial/efeitos dos fármacos , Camundongos , NF-kappa B/metabolismo , Complexo de Proteínas Formadoras de Poros Nucleares/metabolismo , Proteínas de Ligação a RNA/metabolismo , Sesquiterpenos/uso terapêutico , Ensaios Antitumorais Modelo de Xenoenxerto
14.
Mycopathologia ; 175(3-4): 361-3, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23526375

RESUMO

Data guiding management of pulmonary mycetomas are based on uncontrolled trials and case reports. Surgical resection represents a definitive treatment associated with high mortality and sometimes not feasible due to clinical conditions. We report a case of an immunocompetent patient with multiple pulmonary mycetomas, suggestive for probable chronic aspergillosis, in which surgery was contraindicated. The patient experienced a good response to long-term oral voriconazole therapy with remarkable clinical and radiological improvement at three-month follow-up. In cases of probable chronic aspergillomas, when surgery is contraindicated, long-term antifungal therapy with voriconazole seems to be a valid alternative option.


Assuntos
Antifúngicos/administração & dosagem , Micetoma/diagnóstico , Micetoma/tratamento farmacológico , Aspergilose Pulmonar/diagnóstico , Aspergilose Pulmonar/tratamento farmacológico , Pirimidinas/administração & dosagem , Triazóis/administração & dosagem , Idoso , Humanos , Pulmão/diagnóstico por imagem , Pulmão/patologia , Masculino , Micetoma/patologia , Aspergilose Pulmonar/patologia , Radiografia , Resultado do Tratamento , Voriconazol
16.
Panminerva Med ; 54(3): 225-31, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22801440

RESUMO

AIM: It is well known that vitamin D plays an important role in maintaining bone homeostasis and in regulating calcium absorption. The active form of vitamin D interacts with its receptor the VDR that is expressed in multiple tissues and it is involved in platelets (PLTs) function. In the present study we evaluate PLTs' VDR expression in osteoporotic as opposed to healthy subjects. METHODS: We enrolled in the study 77 women with postmenopausal osteoporosis, 33 healthy women of childbearing age, 49 healthy men, and 11 healthy women matched with patients for age and postmenopausal period. Thirty-nine patients had had one femoral fracture occurred after the age of fifty and attributable to primary osteoporosis. Bone mineral density, markers of bone metabolism and VDR levels were measured in all the subjects. RESULTS: Our data show that VDR level is lower in patients as respect to controls and is positively correlated with bone density, but not with markers of bone metabolism. We also found a decrease in the phosphorus levels in patients without differences in vitamin D levels and in the dietary calcium intake. CONCLUSION: The lower VDR expression in osteoporotic could indicate a lower ability to respond to vitamin D, and could be the explanation of the increase in the PTH and decrease in the phosphorus levels in patients with respect to controls.


Assuntos
Plaquetas/citologia , Osteoporose/metabolismo , Receptores de Calcitriol/metabolismo , Vitamina D/metabolismo , Adulto , Idoso , Plaquetas/metabolismo , Densidade Óssea , Osso e Ossos/metabolismo , Relação Dose-Resposta a Droga , Feminino , Fraturas do Fêmur/metabolismo , Humanos , Masculino , Pessoa de Meia-Idade , Fósforo/metabolismo
17.
Ann Trop Med Parasitol ; 105(5): 339-49, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21929875

RESUMO

Nine cases of cryptosporidiosis co-infections in AIDS patients were clinically categorised into severe (patients 1, 3, 8 and 9), moderate (patients 4 and 5) and mild (patients 2, 6 and 7). Formalin-fixed faecal specimens from these patients were treated to obtain high quality DNA competent for amplification and sequencing of the 60-kDa glycoprotein (GP60) gene. Sequence analysis revealed that one patient was infected with Cryptosporidium hominis whereas the remaining eight patients were infected with C. parvum. Interestingly, the patients showing severe cryptosporidiosis harboured two subtypes within the C. parvum allelic family IIc (IIcA5G3 and IIcA5G3R2), whereas patients with moderate or mild infections showed various subtypes of the C. parvum allelic family IIa (IIaA14G2R1, IIaA15G2R1, IIaA17G3R1 and IIaA18G3R1). DNA extraction and genotyping of Cryptosporidium spp. is a challenging task on formalin-fixed stool samples, whose diagnostic outcome is age-dependent. The method herein reported represents a step forward routine diagnosis and improves epidemiology of HIV-related clinical cases. Due to the need to elucidate genetic richness of Cryptosporidium human isolates, this approach represents a useful tool to correlate individual differences in symptoms to subgenotyping lineages.


Assuntos
Infecções Oportunistas Relacionadas com a AIDS/parasitologia , Síndrome da Imunodeficiência Adquirida/complicações , Criptosporidiose/diagnóstico , Cryptosporidium parvum/genética , Fezes/parasitologia , Proteínas de Protozoários/genética , Adulto , Sequência de Bases , Coinfecção , Criptosporidiose/parasitologia , Cryptosporidium/genética , Cryptosporidium/metabolismo , Cryptosporidium parvum/metabolismo , DNA de Protozoário/genética , Feminino , Fixadores , Formaldeído , Genótipo , Humanos , Masculino , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase , Proteínas de Protozoários/classificação , Proteínas de Protozoários/isolamento & purificação , Estudos Retrospectivos , Análise de Sequência de DNA , Especificidade da Espécie
18.
Curr HIV Res ; 9(4): 270-5, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21631426

RESUMO

BACKGROUND: Kaposi's sarcoma is commonly described in HIV/AIDS patients but usually manifests as overt skin lesions or visceral involvement. Bone involvement, particularly vertebral, is uncommon, especially when there is no adjacent cutaneous lesion but a small number of cases have been reported. Unlike many other diseases associated with HIV, Kaposi's sarcoma can occur despite a normal CD4 count. CASE PRESENTATION: A 44 year-old HIV positive Nigerian man presented with a 20 day history of severe, worsening lumbar back pain, nearly three years after an earlier diagnosis of a single cutaneous lesion consistent with Kaposi's sarcoma, for which he received chemo-radiotherapy. Despite varying previous compliance with his anti-retroviral therapy, he was thought to be taking his medications at time of presentation and his CD4 count was 408 cells/mm(3). No other organ involvement was found but a pathological fracture was seen on magnetic resonance imaging affecting L1 vertebra. A CT-guided needle aspiration biopsy was performed and a histological diagnosis subsequently confirmed Kaposi's sarcoma. The patient was treated with further courses of radiotherapy but had little clinical improvement. Indeed, a follow-up MRI four months later showed new involvement of a further four vertebrae, fortunately in the absence of progressive focal neurology. CONCLUSION: Vertebral Kaposi's sarcoma is a rare diagnosis but can be accurately diagnosed with CT or MRI imaging in conjunction with a histological diagnosis. An immunosuppressed patient presenting with bone pain should be thoroughly investigated for Kaposi's sarcoma as modern chemotherapeutic agents alongside anti-retroviral therapy may delay or prevent further devastating complications such as spinal cord compression.


Assuntos
Síndrome da Imunodeficiência Adquirida/complicações , Vértebras Lombares , Sarcoma de Kaposi/secundário , Neoplasias Cutâneas , Fraturas da Coluna Vertebral/etiologia , Neoplasias da Coluna Vertebral/secundário , Adulto , Fraturas Espontâneas/etiologia , Humanos , Perna (Membro) , Vértebras Lombares/lesões , Imageamento por Ressonância Magnética , Masculino , Sarcoma de Kaposi/radioterapia , Neoplasias da Coluna Vertebral/radioterapia , Resultado do Tratamento
19.
Ann Thorac Med ; 4(4): 163-72, 2009 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-19881161

RESUMO

In the 4 months since it was first recognized, the pandemic strain of a novel influenza A (H1N1) virus has spread to all continents and, after documentation of human-to-human transmission of the virus in at least three countries in two separate World Health Organization (WHO) regions, the pandemic alert was raised to level 6. The agent responsible for this pandemic, a swine-origin influenza A (H1N1) virus (S-OIV), is characterized by a unique combination of gene segments that has not previously been identified among human or swine influenza A viruses. As of 31th July 2009, 168 countries and overseas territories/communities have each reported at least one laboratory-confirmed case of pandemic H1N1 infection. There have been a total of 162,380 reported cases and 1154 associated deaths. Influenza epidemics usually take off in autumn, and it is important to prepare for an earlier start this season. Estimates from Europe indicate that 230 millions Europe inhabitants will have clinical signs and symptoms of S-OIV this autumn, and 7- 35% of the clinical cases will have a fatal outcome, which means that there will be 160,000- 750,000 H1N1-related deaths. A vaccine against H1N1 is expected to be the most effective tool for controlling influenza A (H1N1) infection in terms of reducing morbidity and mortality and limiting diffusion. However, there are several issues with regard to vaccine manufacture and approval, as well as production capacity, that remain unsettled. We searched the literature indexed in PubMed as well as the websites of major international health agencies to obtain the material presented in this update on the current S-OIV pandemic.

20.
Minerva Gastroenterol Dietol ; 55(2): 139-43, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19305373

RESUMO

The progression of chronic liver diseases is characterized by a common histopathological pathway comprising fibrosis formation and distortion of hepatic architecture which are the hallmark of evolution to cirrhosis. Several factors are responsible for the severity and progression of chronic hepatitis C. Here, we describe the most important data regarding the association between regular smoking and histological hepatic lesions. Some reports have shown that the proportion of patients with moderate or significant histological activity gradually increases with the daily consumption of tobacco. Moreover, fibrosis is associated with regular smoking in some studies. However, controversies result from other studies. Nicotine is mainly metabolised by the liver, and its administration in experimental animals showed development of steatosis and focal or confluent hepatic necrosis, probably linked to the oxidative stress associated with lipid peroxidation. In chronic hepatitis C patients, preliminary studies have suggested that hypoxia caused by smoking may induce expression of the cytokines vascular endothelial growth factor (VEGF) and VEGF-D and their corresponding soluble tyrosine kinase receptors fms-like tyrosine kinase receptor and kinase insert domain receptor. Since this issue is controversial and smoking is in any case unsafe, stopping is recommended for patients with liver diseases.


Assuntos
Hepatite C Crônica/patologia , Fumar/efeitos adversos , Animais , Citocinas/metabolismo , Progressão da Doença , Medicina Baseada em Evidências , Hepatite C Crônica/complicações , Hepatite C Crônica/diagnóstico , Hepatite C Crônica/metabolismo , Humanos , Hipóxia/induzido quimicamente , Peroxidação de Lipídeos/efeitos dos fármacos , Cirrose Hepática/etiologia , Cirrose Hepática/patologia , Estresse Oxidativo/efeitos dos fármacos , Prognóstico , Receptores Proteína Tirosina Quinases/efeitos dos fármacos , Fatores de Risco , Índice de Gravidade de Doença , Fator A de Crescimento do Endotélio Vascular/efeitos dos fármacos , Fator D de Crescimento do Endotélio Vascular/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...